Drug Topics

OCTOBER 20, 2023

Despite societal need, stigma around MAT and MOUD still exists.

551

551

STAT

OCTOBER 20, 2023

When she stopped getting her period in March 2022, Daryn Schwartz wasn’t especially concerned. At 42, she had recently come off birth control, and figured her cycles were still adjusting. When it hadn’t come back by the summer, she sought gynecological care, but was told to wait it out. So she did, with no changes. She was having other symptoms, too — fatigue, chronic pain, and difficulty focusing.

145

145

Drug Topics

OCTOBER 20, 2023

An ounce of prevention is well worth a pound of cure when it comes to DEA investigations.

307

307

STAT

OCTOBER 20, 2023

A doctor, a patient advocate, and the most powerful figure in the methadone treatment industry presented competing visions for the future of American addiction medicine this week — a conversation that touched on stigma, patients’ rights, and a stark divide in health provider attitudes toward patients with addiction. The debate centered on a single question: whether U.S. doctors should be able to prescribe methadone, a medication used to treat addiction to drugs like fentanyl and he

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 20, 2023

Research findings may support further COVID-19 vaccination in children.

Vaccines 281

Vaccines 281

Pharmacy Times

OCTOBER 20, 2023

Penbraya (Pfizer Inc) is the first and only approved pentavalent vaccine that confers protection against the most common meningococcal serogroups—A, B, C, W-135, and Y, in individuals 10 through 25 years of age.

Vaccines 145

Vaccines FDA 145

Pharmacy Times

OCTOBER 20, 2023

Women with HIV reported higher rates of physical abuse than men with HIV, but women had more social support from family and friends.

139

139

Fierce Healthcare

OCTOBER 20, 2023

Three out of four Americans don’t trust artificial intelligence in a healthcare setting, and most have no idea whether their provider is already using the technology, a new survey has found. | Many respondents admitted their understanding of AI is limited, and half would not be comfortable with it in the healthcare setting. But most said if their practice was transparent about its AI use, that would help them feel more comfortable.

134

134

STAT

OCTOBER 20, 2023

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars? At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology , which was acquired by Eli

134

134

Pharmacy Times

OCTOBER 20, 2023

In addition to celebrating his colleagues, Medrano said he is taking more time for mindfulness and meditation before going to work each day.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 20, 2023

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug. The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also publish

133

133

Pharmacy Times

OCTOBER 20, 2023

Biktarvy was found both effective and safe for long-term use in HIV, as well as for patients with mental health conditions.

132

132

STAT

OCTOBER 20, 2023

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated. In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceutical Companies 130

Pharmacy Times

OCTOBER 20, 2023

In a recent study, approximately 99% of children who received solid organ transplant and live vaccination against rubella had antibodies 1 to 3 months post-vaccination.

Vaccines 132

Vaccines 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

OCTOBER 20, 2023

It shouldn't come as much of a surprise that employers are putting a focus on managing healthcare costs in the coming year. | It shouldn't come as much of a surprise that employers are putting a focus on managing healthcare costs in the coming year.

130

130

STAT

OCTOBER 20, 2023

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance. Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

Compounding 127

Compounding Chemotherapy Hospitals 127

Pharmacy Times

OCTOBER 20, 2023

An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.

Vaccines 123

Vaccines 123

STAT

OCTOBER 20, 2023

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine. The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022.

FDA 127

FDA Documentation 127

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

OCTOBER 20, 2023

Ongoing national medication, medical supply and medical equipment shortages are harming patients, a new survey reveals. | Providing appropriate care has become increasingly difficult, leading to instances of unsafe practices, compromised care and harmful, otherwise avoidable patient safety incidents, the survey found.

122

122

STAT

OCTOBER 20, 2023

Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad. He saw his brother excel at what he did, but Pratt’s life changed in 2012 when his brother was shot and killed in Chicago’s South Side. “The most important thing that his life represented for me was that he relieved me of the burden to prove myself,” Pratt said.

122

122

Fierce Healthcare

OCTOBER 20, 2023

Kaiser Permanente is expanding its medical-legal partnership program to bring housing-related legal services to members and communities across seven of its regions. | The program is in partnership with the National Center for Medical-Legal Partnership and Health Begins. The partners estimate they can help prevent evictions and access housing-related legal aid for thousands of community residents and Kaiser members by 2025.

119

119

STAT

OCTOBER 20, 2023

As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S. International Trade Commission against nearly a dozen online pharmacies that are allegedly selling unapproved versions of the Mounjaro diabetes drug, which is frequently used to combat obesity. The drugmaker maintained the companies are marketing “low grade” versions of products purporting to contain tirzepatide, which is the active pharmaceutical ingredient in Mounjaro.

117

117

Drug Store News

OCTOBER 20, 2023

Flu activity is 66% lower than this time last year, but it is 34% higher when looking at pre-pandemic seasons, such as 2018-2019.

116

116

pharmaphorum

OCTOBER 20, 2023

How quality of life can drive equitable cancer care and outcomes Mike.

116

116

Fierce Healthcare

OCTOBER 20, 2023

Folx Health, a virtual provider focused on LGBTQ+ health, is now in-network with Cigna, Evernorth and Blue Shield of California. | Until August, Folx operated under a membership model in a lump sum subscription package. It has since been updated to accept insurance as a part of the core membership structure.

Packaging 116

Packaging Insurance 116

European Pharmaceutical Review

OCTOBER 20, 2023

A paper by Tim Sandle, Head of Microbiology, Risk Management and Sterility Assurance at Bio Products Laboratory Ltd has underlined the importance of proper cleanroom disinfection practices by elucidating on the robust survival mechanism of the bacterium Micrococcus luteus (M. luteus). As “one of the most abundant organisms on the outer layer of human skin” M. luteus is a common contaminant recovered from cleanrooms, according to Sandle.

116

116

pharmaphorum

OCTOBER 20, 2023

At CAR-TCR last month in Boston, pharmaphorum Editor in Chief Jonah Comstock grabbed some time with Tim McGuire, director of business development at biomanufacturer Resilience.

115

115

STAT

OCTOBER 20, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

115

115

Drug Store News

OCTOBER 20, 2023

CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine from its shelves and will no longer sell them.

111

111

STAT

OCTOBER 20, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda: a trip to check in on the Pharmalot ancestors, tidying up the official grounds, and some overdue promenading with the official mascots. If time permits, we may also hold a listening party and, if so, the playlist may include this , this , this and this.

112

112

pharmaphorum

OCTOBER 20, 2023

EU clears path for Pfizer’s takeover of Seagen Phil.

111

111

Outsourcing Pharma

OCTOBER 20, 2023

A small molecule kinase inhibitor has been trialed in humans for the first time as part of a glioblastoma treatment study.

111

111

European Pharmaceutical Review

OCTOBER 20, 2023

According to sustainability results from CPHI’s Annual Survey 2023, sustainability goals and metrics are now being implemented across the pharma supply chain , with the rate of adoption accelerating quickly. Most contract development and manufacturing organisations (CDMOs) are expected to use them within the next two years. This is a significant shift from last year’s survey when the expectation was that changes would take up to five years, the data showed.

Process Improvement 109

Process Improvement 109